Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.30 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25403873 | 0.80 | TSHR (0.39) | CA2TSHRUSP2CA1MAPK1 | |
| SCHEMBL11561311 | 0.79 | CA2 (0.46) | CA2TSHRCA1MAPK1CYP3A4 | |
| SCHEMBL2575879 | 0.78 | CA2 (0.39) | CA2TSHRCYP3A4ATMTDP1 | |
| SCHEMBL28969956 | 0.78 | CA2 (0.44) | CA2TSHRCA1CYP3A4ATM | |
| SCHEMBL16338750 | 0.77 | CA2 (0.44) | CA2CA1MAPK1 | |
| SCHEMBL12561138 | 0.75 | TSHR (0.42) | CA2TSHRCA1CYP3A4ATM | |
| SCHEMBL30835554 | 0.75 | HAO1 (0.52) | MAPK1 | |
| SCHEMBL20838317 | 0.75 | TDP1 (0.45) | CA2TSHRMAPK1CYP3A4ATM | |
| SCHEMBL15659854 | 0.75 | TDP1 (0.45) | CA2TSHRUSP2CA1MAPK1 | |
| Potassium SCHEMBL31652342 | 0.74 | USP2 (0.50) | CA2TSHRUSP2CA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692132-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11692132-B2 | Organic electroluminescent materials and devices | OSBP, OCIAD1, OCIAD2 | CA2 3386/4885TSHR 2959/4885USP2 4810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.